Results:
This is the name of the game!

Top team: What has pharmexx been doing in order to become a strategic partner rather than simply an operational partner?
Georg Nagl: Every single day the Pharmaceutical Industry suffers governmental restrictions all over the world which restricts the commercial activities as well as the strategic ones. A CSO like pharmexx, which provides international business platform, allows a successful model so that it can be used anywhere in the world by having a single and reliable partner.

Tt: Ok, it might be an advantage, however, why contracting a CSO?
GN: The pharmaceutical industries have faced an increasingly changing business environment, so a CSO can set up sales teams very efficiently without affecting their daily operations. The industries have faced strong pressure for prices; a CSO might reduce fixed costs by lowering their risk rates. The pharmaceutical industry has faced skeptic customers and market so a CSO allows the possibility of trying new business models whereas preserving the laboratory image, that is, a CSO provides sales increase by lowering costs and risks whereas generating profit.

Tt: Is the executive's safety at stake when hiring a CSO?
GN: It is directly linked to the results he generates to the company and not to the quantity of employees he has. Results, "Bottom line", this is the name of the game.

Tt: What is pharmexx competitive advantage?
GN: Having experienced executives in each country who are aware of and master the local market; searching for high quality services and finally investing on technology and skilled professionals.